CSE/ASEP (CSE/ASEP)

Canadian Securities Exchange: CSE/ASEP · CAD

CA$0.10

+0.00 (0.0%)· Recorded snapshot

Market cap	1.6M
Revenue (ttm)	336.8K
Net income (ttm)	-4.1M
EPS (ttm)	-CA$0.34
Shares out	15.9M
Volume	1,200
Beta	-1.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 336.8K
Net income (ttm): -4.1M
EPS (ttm): -CA$0.34
Market cap: 1.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROE-88.1

P25 -104.1P50 -30P75 6.7

ROIC-15.3

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All CSE/ASEP indicators

Market & fundamental data

Available fields

158

Groups with data

Currency

CAD

Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-01
Employees	3
Employees change	-3
Employees growth	-50%
Enterprise value	CAD 3.9M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2021
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA04368A2048
Last earnings date	2025-11-28
Last refreshed	2026-10-29
Last stock split date	2025-04-17
Last stock split type	Reverse
Market cap	CAD 1.6M
Next earnings date	2026-12-01
Price	CAD 0.10
Price currency	CAD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	cse/ASEP
Website	https://asepmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-342.83%
EV/Sales	11.67x
FCF / EV yield	-31.37%
FCF yield	-77.69%
P/B ratio	0.32x
P/S ratio	4.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-587.47%
Pretax margin	-1,962.92%
ROA	-11.01%
ROA (5Y)	-11.65%
ROCE	-29.91%
ROE	-88.11%
ROE (5Y)	-53.76%
ROIC	-15.33%
Tax / revenue	-16.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	1
Gross profit growth	13.48%
Gross profit growth (Q)	0%
Net income growth quarters	6
Net income growth years	1
Revenue growth	13.48%
Revenue growth (QoQ)	1.11%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 575,557
EBIT	CAD -2M
EBITDA	CAD -1.4M
EPS	CAD -0.34
FCF per share	CAD -0.08
Financing cash flow	CAD 519,102
Free cash flow	CAD -1.2M
Gross profit	CAD 336,773
Income taxes	CAD -54,000
Investing cash flow	CAD 749,373
Net borrowing	CAD 519,102
Net cash flow	CAD 35,284
Net income	CAD -4.1M
Operating income	CAD -2M
Revenue	CAD 336,773

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-5.25
Book value per share	CAD 0.19
Debt / equity	0.13
Interest coverage	-51.89
Long-term assets	CAD 8.3M
Long-term liabilities	CAD 1.6M
Net cash (debt)	CAD -420,412
Net cash / market cap	-26.49%
Net debt / equity	0.08
Piotroski F-Score	3
Property, plant and equipment	CAD 5,053
Shareholders' equity	CAD 5M
Tangible book value	CAD -3.4M
Tangible book value per share	CAD -0.22
Total assets	CAD 8.5M
Total cash	CAD 215,226
Total debt	CAD 635,638
Total liabilities	CAD 3.6M
WACC	-0.91%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.03
Current assets	CAD 233,153
Current liabilities	CAD 1.9M
Current ratio	0.12
Net working capital	CAD -1.4M
Quick ratio	0.12
Working capital	CAD -1.7M
Working capital turnover	-0.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-40.3%
Shareholder yield	-40.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.46
1D price change	0%
1M price change	-33.33%
1M total return	-33.33%
1W price change	-23.08%
1W total return	-23.08%
20-day SMA	CAD 0.12
200-day SMA	CAD 0.67
3M price change	-23.08%
3M total return	-23.08%
3Y price change	-94.59%
3Y return CAGR	-62.18%
3Y total return	-94.59%
50-day SMA	CAD 0.20
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.50
52-week high date	2025-12-18
52-week low	CAD 0.06
52-week low date	2026-08-14
6M price change	-67.74%
6M total return	-67.74%
All-time high	CAD 10.30
All-time high date	2021-11-24
All-time low	CAD 0.06
All-time low date	2026-08-14
Average true range (ATR)	CAD 0.03
Average volume	20.5K
Beta (1Y)	-3.21
Beta (2Y)	-0.97
Beta (5Y)	-1.35
Change from 52-week high	-80%
Change from 52-week low	81.82%
Change from all-time high	-99.03%
Change from all-time low	81.82%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 120
High price	CAD 0.10
Low price	CAD 0.10
Monthly RSI	33.28
Open price	CAD 0.10
Previous close	CAD 0.10
Price vs 150-day SMA	-78.35%
Price vs 20-day SMA	-19.48%
Price vs 200-day SMA	-85.06%
Price vs 50-day SMA	-49.95%
Relative volume	0.06
RSI	43
Sharpe ratio	0.98
Sortino ratio	3.22
Volume	1.2K
Weekly RSI	39.57
YTD price change	-64.29%
YTD total return	-64.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7.7M
Shares change (QoQ)	31.46%
Shares change (YoY)	40.3%
Shares held by insiders	51.26%
Shares outstanding	15.9M

Deeper analysis on CSE/ASEP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/ASEP report

Is a complete CSE/ASEP research report available?

No complete published report is available for cse/ASEP (CSE/ASEP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/ASEP (CSE/ASEP)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/ASEP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/ASEP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/ASEP

Frequently asked questions